Last month the Kanaph science team had a chance to attend
ENA 2022, the 34th EORTC-NCI-AACR conference in Barcelona.
We were excited to
present our latest development of our KNP-503, SHP2 inhibitor program as well
as converse with scientists and experts in the field of oncology and rare
We appreciate everyone who came out to check out our poster and the
ENA faculty for holding such an important symposium for the global biopharma